USC study reveals potential new treatment target for Alzheimer's disease
Researchers at Keck School of Medicine of USC identify a novel target related to the blood-brain barrier and a potential therapy that offers hope for slowing progression of Alzheimer's disease in people with the APOE4 gene
Like amyloid plaque, the genetic variant APOE4 has long been associated with Alzheimer's disease, but still little is known about the role the gene plays in the disease process.
Now, a new study published in END
Now, a new study published in END